Interneuron, Takeda Chemical deal

IPIC received data from a double-blind clinical trial conducted by Takeda in ischemic stroke patients taking citicoline.

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE